Inma Castilla-Cortazar
Overview
Explore the profile of Inma Castilla-Cortazar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martin-Estal I, Fajardo-Ramirez O, de Leon M, Zertuche-Mery C, Rodriguez-Mendoza D, Gomez-Alvarez P, et al.
F1000Res
. 2024 Dec;
10:1284.
PMID: 39640427
Background: During pregnancy, the placenta is an extremely important organ as it secretes its own hormones, insulin-like growth factor 1 (IGF-1), to ensure proper intrauterine fetal growth and development. Ethanol,...
2.
Martin-Estal I, Fajardo-Ramirez O, de Leon M, Zertuche-Mery C, Benavides-Guajardo R, Garcia-Cruz M, et al.
Biology (Basel)
. 2022 Sep;
11(9).
PMID: 36138743
Ethanol use during pregnancy is a risk factor for developing adverse outcomes. Its metabolism by cytochrome P450 2E1 (CYP2E1) produces radical oxygen species (ROS), promoting cellular injury and apoptosis. To...
3.
Martin-Estal I, Castilla-Cortazar I, Castorena-Torres F
Rev Physiol Biochem Pharmacol
. 2021 Jun;
180:119-153.
PMID: 34159446
Alcohol is one of the most consumed drugs in the world, even during pregnancy. Its use is a risk factor for developing adverse outcomes, e.g. fetal death, miscarriage, fetal growth...
4.
Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study
De Diego M, Gomez-Pardo O, Groar J, Lopez-Escobar A, Martin-Estal I, Castilla-Cortazar I, et al.
Arch Gynecol Obstet
. 2020 Aug;
302(5):1169-1179.
PMID: 32770354
Purpose: To investigate the metabolic impact of currently used therapies in polycystic ovary syndrome (PCOS). Methods: This is an observational, retrospective and transversal protocol. A small cohort of 133 patients,...
5.
Femat-Roldan G, Gaitan Palau M, Castilla-Cortazar I, Elizondo Ochoa G, Moreno N, Martin-Estal I, et al.
Parkinsons Dis
. 2020 Apr;
2020:8060259.
PMID: 32257099
Background: Weight loss in Parkinson's disease (PD) patients is a common but poorly understood manifestation. Several studies have reported that weight changes could be related to motor symptoms, drug side...
6.
Castilla-Cortazar I, Aguirre G, Femat-Roldan G, Martin-Estal I, Espinosa L
J Transl Med
. 2020 Feb;
18(1):70.
PMID: 32046737
Parkinson's disease (PD) is a neurodegenerative disorder that results in the death of dopaminergic neurons within the substantia nigra pars compacta and the reduction in dopaminergic control over striatal output...
7.
Castilla-Cortazar I, De Ita J, Garcia-Magarino M, Aguirre G, Castorena-Torres F, Valdez-Garcia J, et al.
Am J Case Rep
. 2019 May;
20:689-696.
PMID: 31086127
BACKGROUND Growth hormone insensitivity and reduced levels of insulin-like growth factor-1 (IGF-1) are associated with metabolic syndrome that includes obesity, hyperglycemia, type 2 diabetes mellitus, and dyslipidemia. Laron syndrome is...
8.
Castilla-Cortazar I, Iturrieta I, Garcia-Magarino M, Puche J, Martin-Estal I, Aguirre G, et al.
Neuroscience
. 2019 Feb;
404:445-458.
PMID: 30708048
Neurotrophic factors (NTFs) are a relevant group of secreted proteins that modulate growth, differentiation, repair, and survival of neurons, playing a role in the maintenance of the synaptic unions, dendrites,...
9.
Castilla-Cortazar I, Rodriguez De Ita J, Aguirre G, Rodriguez-Rivera J, Garcia-Magarino M, Martin-Estal I, et al.
Clin Case Rep
. 2018 Feb;
6(2):426-431.
PMID: 29445490
We report a case of short stature irresponsive to growth hormone (GH) replacement therapy. Low GH response to provocative tests and undetectable IGF-1 levels had suggested GH deficiency, while response...
10.
Aguirre G, Gonzalez-Guerra J, Espinosa L, Castilla-Cortazar I
Rev Physiol Biochem Pharmacol
. 2018 Jan;
175:1-45.
PMID: 29294200
Non-communicable diseases, such as cardiovascular diseases, are the leading cause of mortality worldwide. For this reason, a tremendous effort is being made worldwide to effectively circumvent these afflictions, where insulin-like...